207 related articles for article (PubMed ID: 27322055)
1. RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation.
Xie Q; Wu Q; Kim L; Miller TE; Liau BB; Mack SC; Yang K; Factor DC; Fang X; Huang Z; Zhou W; Alazem K; Wang X; Bernstein BE; Bao S; Rich JN
J Clin Invest; 2016 Jul; 126(7):2757-72. PubMed ID: 27322055
[TBL] [Abstract][Full Text] [Related]
2. γ-Secretase inhibitor-resistant glioblastoma stem cells require RBPJ to propagate.
Fan X
J Clin Invest; 2016 Jul; 126(7):2415-8. PubMed ID: 27322058
[TBL] [Abstract][Full Text] [Related]
3. Loss of the Notch effector RBPJ promotes tumorigenesis.
Kulic I; Robertson G; Chang L; Baker JH; Lockwood WW; Mok W; Fuller M; Fournier M; Wong N; Chou V; Robinson MD; Chun HJ; Gilks B; Kempkes B; Thomson TA; Hirst M; Minchinton AI; Lam WL; Jones S; Marra M; Karsan A
J Exp Med; 2015 Jan; 212(1):37-52. PubMed ID: 25512468
[TBL] [Abstract][Full Text] [Related]
4. RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway.
Zhang G; Tanaka S; Jiapaer S; Sabit H; Tamai S; Kinoshita M; Nakada M
Cancer Sci; 2020 Nov; 111(11):4166-4176. PubMed ID: 32885530
[TBL] [Abstract][Full Text] [Related]
5. SNW1 regulates Notch signaling in neuroblastoma through interacting with RBPJ.
Hong M; He J; Li S
Biochem Biophys Res Commun; 2019 Feb; 509(4):869-876. PubMed ID: 30642633
[TBL] [Abstract][Full Text] [Related]
6. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
7. Transcription Factor RBPJ as a Molecular Switch in Regulating the Notch Response.
Giaimo BD; Gagliani EK; Kovall RA; Borggrefe T
Adv Exp Med Biol; 2021; 1287():9-30. PubMed ID: 33034023
[TBL] [Abstract][Full Text] [Related]
8. TRBP maintains mammalian embryonic neural stem cell properties by acting as a novel transcriptional coactivator of the Notch signaling pathway.
Byun SH; Kim J; Han D; Kwon M; Cho JY; Ng HX; Pleasure SJ; Yoon K
Development; 2017 Mar; 144(5):778-783. PubMed ID: 28174252
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation of a GC repressor element in the smooth muscle myosin heavy chain promoter facilitates binding of the Notch-associated transcription factor, RBPJ/CSL1.
Rozenberg JM; Tesfu DB; Musunuri S; Taylor JM; Mack CP
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2624-31. PubMed ID: 25324571
[TBL] [Abstract][Full Text] [Related]
10. An RBPJ-
Gahr BM; Brändle F; Zimmermann M; Nagel AC
Cells; 2019 Oct; 8(10):. PubMed ID: 31615108
[TBL] [Abstract][Full Text] [Related]
11. RBPJ/CBF1 interacts with L3MBTL3/MBT1 to promote repression of Notch signaling via histone demethylase KDM1A/LSD1.
Xu T; Park SS; Giaimo BD; Hall D; Ferrante F; Ho DM; Hori K; Anhezini L; Ertl I; Bartkuhn M; Zhang H; Milon E; Ha K; Conlon KP; Kuick R; Govindarajoo B; Zhang Y; Sun Y; Dou Y; Basrur V; Elenitoba-Johnson KS; Nesvizhskii AI; Ceron J; Lee CY; Borggrefe T; Kovall RA; Rual JF
EMBO J; 2017 Nov; 36(21):3232-3249. PubMed ID: 29030483
[TBL] [Abstract][Full Text] [Related]
12. Notch-Rbpj signaling is required for the development of noradrenergic neurons in the mouse locus coeruleus.
Shi M; Hu ZL; Zheng MH; Song NN; Huang Y; Zhao G; Han H; Ding YQ
J Cell Sci; 2012 Sep; 125(Pt 18):4320-32. PubMed ID: 22718343
[TBL] [Abstract][Full Text] [Related]
13. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
[TBL] [Abstract][Full Text] [Related]
14. Dynamic binding of RBPJ is determined by Notch signaling status.
Castel D; Mourikis P; Bartels SJ; Brinkman AB; Tajbakhsh S; Stunnenberg HG
Genes Dev; 2013 May; 27(9):1059-71. PubMed ID: 23651858
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genomic features indicative for Notch responsiveness.
Giaimo BD; Friedrich T; Ferrante F; Bartkuhn M; Borggrefe T
Nucleic Acids Res; 2024 May; 52(9):5179-5194. PubMed ID: 38647081
[TBL] [Abstract][Full Text] [Related]
16. CDC20 maintains tumor initiating cells.
Xie Q; Wu Q; Mack SC; Yang K; Kim L; Hubert CG; Flavahan WA; Chu C; Bao S; Rich JN
Oncotarget; 2015 May; 6(15):13241-54. PubMed ID: 25938542
[TBL] [Abstract][Full Text] [Related]
17. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
18. RBPJ is a novel target for rhabdomyosarcoma therapy.
Nagao H; Setoguchi T; Kitamoto S; Ishidou Y; Nagano S; Yokouchi M; Abematsu M; Kawabata N; Maeda S; Yonezawa S; Komiya S
PLoS One; 2012; 7(7):e39268. PubMed ID: 22792167
[TBL] [Abstract][Full Text] [Related]
19. Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish.
O'Brien LL; Grimaldi M; Kostun Z; Wingert RA; Selleck R; Davidson AJ
Dev Biol; 2011 Oct; 358(2):318-30. PubMed ID: 21871448
[TBL] [Abstract][Full Text] [Related]
20. Notch-dependent and -independent functions of transcription factor RBPJ.
Friedrich T; Ferrante F; Pioger L; Nist A; Stiewe T; Andrau JC; Bartkuhn M; Giaimo BD; Borggrefe T
Nucleic Acids Res; 2022 Aug; 50(14):7925-7937. PubMed ID: 35848919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
